Schedule a Call


Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

Book a Conference Call
Get More Information

Elminda, Ltd

Location: Herzliya, Israel

Sector: Life Sciences

Industry: MedTech

Add to Shortlist
Express Interest

Headquarters and R&D in Israel, US subsidiary.

Elminda is a unique neuro-technology company harnessing data science and Artificial Intelligence to change the way we diagnose and treat brain disease. We have a team of world-class multi-disciplinary scientists, physicians, engineers and business entrepreneurs.

Wide IP coverage and the world’s largest database of brain function information.

25+ active sites (US, China, Europe, Israel)



Inside view to Florida’s largest retirement community use of BNA technology 



Recent News

Solving a problem – Critical need

Today, brain diagnosis and treatment selection is largely based on subjective measures or imaging modalities that shed little light on brain function. Elminda’s BNA™ technology provides an objective, reliable and repeatable way of measuring the brain functions


Market size

Brain diseases affect more than 2 billion people. It is a $3 trillion problem. We currently address 2 Major Societal & Clinical Needs:  Brain Wellness or Annual Brain Checkup – enables early detection of potential abnormalities due to aging or incidence and monitor progress and impact of interventions. Total market exceeds 1 Billion people worldwide.

Brain Disorders:  depression, as a first market, affects 322 Million people worldwide


The team

Our multi-disciplinary team combines expertise in neuroscience, signal processing, big data analytics, artificial intelligence, engineering, medicine, cloud computing as well as business and finance with proven track record


Intellectual Property

Wide coverage and protection of intellectual property with 61 patents & patents applications, 3 trade secrets, and the world’s largest & rapidly growing proprietary human brain function with clinical information database


Competitive Edge

Creating a new category in the industry and significant barrier for entry, leading a digital brain health revolution


Regulation / Certification

FDA /CE cleared solution

Unique database

400K brain recordings of EEG/ ERP/ BNA with clinical information

Clinical grade database for comparison of healthy and pathological datasets

Initial market adoption

Initial market adoption with available insurance reimbursement codes

Demonstration of high-value business model

Install base systems across various demographics – US/Europe/China/Israel



Signal and data quality

Automatic real time signal quality assessment, noise detection and cleaning using machine learning

High stability and reproducibility

Standardization and harmonization

Provides standardization in a highly un-regulated field

Makes EEG install based compatible (hardware independence)

Clinical validation

Core methodology is supported by over 10,000 publications

Provides cognitive functions assessment with electrophysiology

Provides clinical neuro-markers for prediction and diagnosis

Comprehensive approach and methodologies suitable for multiple clinical needs

Dr. Arun Menawat, Chairman of the Board

An accomplished history of executive leadership success in the healthcare industry leading companies from start‐up to fast growth success. Dr. Menawat served as the President, CEO and Chairman of Novadaq Technologies Inc., leading the company from start‐up, to successful IPO, to leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures.

Served as President and CEO at Cedara Software, which was sold to Merge Healthcare and ultimately to IBM for their Watson program. Ph.D. in Chemical (Bio) Engineering from the University of Maryland, while concurrently completing a fellowship in biomedical engineering at the NIH, Executive MBA from Kellogg School of Management. In 2014, Dr. Menawat was named the EY Ontario Entrepreneur of the Year in the health sciences category.


Mr. Ronen Gadot, CEO

The first investor in elminda, recognizing the significant unmet need in the diagnostics and treatment of brain related disorders. Entrepreneurial leader of creative solutions that are making a difference, he was selected by the World Economic Forum to serve on the council for the future of neurotechnologies and brain sciences.

Previously held several positions at Silicon Valley based Applied Materials, co‐founded Philips’ Global Corporate Venture arm, making Philips one of the most active corporate investors in Israel, and CEO of the European subsidiary of one of Philips portfolio companies, SHL Telemedicine. Former F‐16 pilot and member of the IAF Aerobatic Team, holds a BSc in Industrial Engineering and an MBA from INSEAD.


Prof. Amir Geva, CTO

Founded elminda in 2006 following over 30 years of brain related research conducted as part of his academic and entrepreneurial career. Prof. and head of the Biomedical Laboratory of the Electrical, & Computer Engineering department at the Ben Gurion University and a visiting Prof. at the Technion Institute of Technology. Experienced entrepreneur and founder of companies with a significant managerial track record. Accomplished scientist, with years of brain and EEG research and experience initiated at the research unit of the Israeli Navy.

A worldwide expert in biomedical signal processing and pattern recognition and pioneer in the use of Artificial Intelligence in healthcare with dozens of academic publications in scientific journals and books. Holds a B.Sc, M.Sc and D.Sc. in Electrical and Computer Engineering and Biomedical engineering from the Technion Institute of Technology.


Mr. Geri Katz, CFO

Vast experience as a CFO of private and publicly traded companies, including PowerDsine, (Nasdaq: PDSN) as well as prior COO and CEO of private companies. Experience includes a successful IPO and M&A. BA in Economics and Accounting, CPA


Dr. Roni Sharon, Medical Director

Board‐Certified Neurologist in the United States and Israel, and currently Director of Headache and Facial pain at Sheba Medical Center. He completed a fellowship at Harvard Medical School’s Brigham and Women’s Hospital in Boston, MA following a residency in Neurology at Mount Sinai Beth Israel in New York, NY. He has years of clinical experience, with many academic publications, and lectures internationally on the subjects of neurology, brain health and wellness.


Dr. Ziv Peremen, VP Medical & Pharma Solutions

An experienced leader with a diverse background in physics, cognitive neuroscience and business development. A lecturer at Tel Aviv University. Holds a BSc in Physics and Philosophy and a PhD in Cognitive Neuroscience from Tel Aviv University.


Mrs. Tanya Damm Bokobza, VP Wellness Solutions

An award winning Industrial Designer & experienced entrepreneur. Previously served as the CEO of a B2B2C, 3D printing pioneering platform as a Google sponsored Entrepreneur. Holds a BFA with honors in Industrial design from RISD and MA Innovation Studies from The academy of art Bezalel.


Mrs. Chen Golan, VP HR & Operations

A hands‐on logistics professional with a multi‐tasking skill set which includes planning, directing, producing and coordinating activities and operations. Specializes in mass media communications.